Insider Transactions in Q4 2024 at Checkpoint Therapeutics, Inc. (CKPT)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 20
2024
|
James F Oliviero Iii CEO, President and Director |
SELL
Bona fide gift
|
Direct |
900,000
-28.17%
|
-
|
|
Dec 19
2024
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
220,230
-6.45%
|
$660,690
$3.38 P/Share
|
|
Dec 18
2024
|
William Garrett Gray Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
268,432
-20.63%
|
$1,073,728
$4.01 P/Share
|
|
Dec 18
2024
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
602,167
-14.99%
|
$1,806,501
$3.87 P/Share
|
|
Dec 13
2024
|
Neil Herskowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,638
+11.57%
|
-
|
|
Dec 13
2024
|
Christian Bechon Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,994
+10.38%
|
-
|
|
Dec 13
2024
|
William Garrett Gray Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
629,000
+32.59%
|
-
|
|
Dec 13
2024
|
James F Oliviero Iii CEO, President and Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,077,700
+34.09%
|
-
|
|
Dec 13
2024
|
Lindsay A Md Rosenwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,638
+8.03%
|
-
|
|
Dec 13
2024
|
Barry M Salzman Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,638
+11.57%
|
-
|
|
Dec 13
2024
|
Michael S Weiss Director |
BUY
Grant, award, or other acquisition
|
Indirect |
12,638
+9.19%
|
-
|